True Leaf Engages Boustead Securities to Underwrite Regulation A+ Offering Vancouver, Canada ? (October 12, 2017) ? True Leaf Medicine International Ltd. (?True Leaf?) (CSE: MJ) (FSE: TLA) (OTCQB: TRLFF), a company involved in the hemp and cannabis-based product industry, has filed a preliminary offering circular with the Securities and Exchange Commission (?SEC?) pursuant to the Regulation A framework, which is open to both accredited and unaccredited investors.
True Leaf has engaged Boustead Securities, LLC Member: FINRA/SIPC (?Boustead?), as lead underwriter. ?Boustead looks forward to working with True Leaf?s team to bring their Regulation A+ offering to investors,? commented David Dobkin of Boustead.
?We are pleased to have Boustead leading the effort,? said True Leaf CEO Darcy Bomford, ?their expertise in Regulation A has proven successful in the past.?
The purpose of the filing is to issue new shares of common stock to raise gross proceeds of up to $10 million CAD to help grow the True Leaf Pet division, and to advance the efforts of the True Leaf Medicine division with the goal of becoming a licensed producer of medicinal cannabis in Canada. Once its Regulation A+ offering has been qualified by the SEC, the offering will be made available to the general public to invest in True Leaf.
|